Published in J Exp Med on January 01, 1996
Biologic activity of cytotoxic T lymphocyte-associated antigen 4 antibody blockade in previously vaccinated metastatic melanoma and ovarian carcinoma patients. Proc Natl Acad Sci U S A (2003) 5.49
Dramatic increase in the numbers of functionally mature dendritic cells in Flt3 ligand-treated mice: multiple dendritic cell subpopulations identified. J Exp Med (1996) 5.32
TRANCE (tumor necrosis factor [TNF]-related activation-induced cytokine), a new TNF family member predominantly expressed in T cells, is a dendritic cell-specific survival factor. J Exp Med (1997) 3.59
From genes to drugs: targeted strategies for melanoma. Nat Rev Cancer (2012) 2.46
Dendritic cells as adjuvants for immune-mediated resistance to tumors. J Exp Med (1997) 2.33
Dendritic cells genetically modified with an adenovirus vector encoding the cDNA for a model antigen induce protective and therapeutic antitumor immunity. J Exp Med (1997) 2.12
Antigen expression by dendritic cells correlates with the therapeutic effectiveness of a model recombinant poxvirus tumor vaccine. Proc Natl Acad Sci U S A (1997) 2.11
Skin-derived dendritic cells induce potent CD8(+) T cell immunity in recombinant lentivector-mediated genetic immunization. Immunity (2006) 1.95
Human dendritic cells mediate cellular apoptosis via tumor necrosis factor-related apoptosis-inducing ligand (TRAIL). J Exp Med (1999) 1.88
Dendritic cells induce autoimmune diabetes and maintain disease via de novo formation of local lymphoid tissue. J Exp Med (1998) 1.65
Antigen-dependent and -independent Ca2+ responses triggered in T cells by dendritic cells compared with B cells. J Exp Med (1998) 1.46
Dendritic cell development in culture from thymic precursor cells in the absence of granulocyte/macrophage colony-stimulating factor. J Exp Med (1996) 1.36
Reversal of tolerance to human MUC1 antigen in MUC1 transgenic mice immunized with fusions of dendritic and carcinoma cells. Proc Natl Acad Sci U S A (1998) 1.29
The new vaccines: building viruses that elicit antitumor immunity. Curr Opin Immunol (1996) 1.13
CD1d-restricted T cells regulate dendritic cell function and antitumor immunity in a granulocyte-macrophage colony-stimulating factor-dependent fashion. Proc Natl Acad Sci U S A (2003) 1.06
Induction of CD4(+) T cell-dependent antitumor immunity by TAT-mediated tumor antigen delivery into dendritic cells. J Clin Invest (2002) 1.05
Percutaneous peptide immunization via corneum barrier-disrupted murine skin for experimental tumor immunoprophylaxis. Proc Natl Acad Sci U S A (2000) 1.04
Dendritic cells purified from myeloma are primed with tumor-specific antigen (idiotype) and activate CD4+ T cells. Proc Natl Acad Sci U S A (2000) 0.96
Optimizing dendritic cell-based immunotherapy in multiple myeloma: intranodal injections of idiotype-pulsed CD40 ligand-matured vaccines led to induction of type-1 and cytotoxic T-cell immune responses in patients. Br J Haematol (2010) 0.95
Induction of tumour-specific CD8(+) cytotoxic T lymphocytes by tumour lysate-pulsed autologous dendritic cells in patients with uterine serous papillary cancer. Br J Cancer (2002) 0.95
Regulation of tumor immunity by tumor/dendritic cell fusions. Clin Dev Immunol (2010) 0.94
Prospects for dendritic cell vaccination in persistent infection with hepatitis C virus. J Clin Virol (2004) 0.94
Use of combinatorial peptide libraries to construct functional mimics of tumor epitopes recognized by MHC class I-restricted cytolytic T lymphocytes. J Exp Med (1996) 0.93
Novel adjuvants & delivery vehicles for vaccines development: a road ahead. Indian J Med Res (2013) 0.92
Therapy of established tumour with a hybrid cellular vaccine generated by using granulocyte-macrophage colony-stimulating factor genetically modified dendritic cells. Immunology (1999) 0.92
Optimizing dendritic cell vaccine for immunotherapy in multiple myeloma: tumour lysates are more potent tumour antigens than idiotype protein to promote anti-tumour immunity. Clin Exp Immunol (2012) 0.90
In vivo tumor transfection with superantigen plus cytokine genes induces tumor regression and prolongs survival in dogs with malignant melanoma. J Clin Invest (1998) 0.89
Prevention of gastrointestinal tumors based on adenomatous polyposis coli gene mutation by dendritic cell vaccine. J Clin Invest (2004) 0.88
Tumour-specific cytotoxic T lymphocyte activity in Th2-type Sézary syndrome: its enhancement by interferon-gamma (IFN-gamma) and IL-12 and fluctuations in association with disease activity. Clin Exp Immunol (1998) 0.88
Whole virus influenza vaccine activates dendritic cells (DC) and stimulates cytokine production by peripheral blood mononuclear cells (PBMC) while subunit vaccines support T cell proliferation. Clin Exp Immunol (1998) 0.85
Induction of human papillomavirus type 16-specific immunologic responses in a normal and an human papillomavirus-infected populations. Immunology (2005) 0.85
Dendritic cells infected with poxviruses encoding MART-1/Melan A sensitize T lymphocytes in vitro. J Immunother (1997) 0.85
Tumor antigens discovery: perspectives for cancer therapy. Mol Med (1997) 0.79
Cimetidine modulates the antigen presenting capacity of dendritic cells from colorectal cancer patients. Br J Cancer (2002) 0.78
Inflammation and TCR signal strength determine the breadth of the T cell response in a bim-dependent manner. J Immunol (2013) 0.78
Immunologic monitoring of cellular responses by dendritic/tumor cell fusion vaccines. J Biomed Biotechnol (2011) 0.77
Protective CD8+ T-cell responses to cytomegalovirus driven by rAAV/GFP/IE1 loading of dendritic cells. J Transl Med (2008) 0.75
The dendritic cell system and its role in immunogenicity. Annu Rev Immunol (1991) 23.09
Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor. J Exp Med (1992) 22.13
Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity. Proc Natl Acad Sci U S A (1993) 11.95
Proliferating dendritic cell progenitors in human blood. J Exp Med (1994) 7.67
GM-CSF and TNF-alpha cooperate in the generation of dendritic Langerhans cells. Nature (1992) 7.41
Role of bone marrow-derived cells in presenting MHC class I-restricted tumor antigens. Science (1994) 6.73
Activation of human dendritic cells through CD40 cross-linking. J Exp Med (1994) 6.16
Granulocyte/macrophage colony-stimulating factor is essential for the viability and function of cultured murine epidermal Langerhans cells. J Exp Med (1987) 5.64
Dendritic cells pulsed with protein antigens in vitro can prime antigen-specific, MHC-restricted T cells in situ. J Exp Med (1990) 5.35
Tumor rejection after direct costimulation of CD8+ T cells by B7-transfected melanoma cells. Science (1993) 5.30
Identification of proliferating dendritic cell precursors in mouse blood. J Exp Med (1992) 5.03
Costimulation of antitumor immunity by the B7 counterreceptor for the T lymphocyte molecules CD28 and CTLA-4. Cell (1992) 4.34
The tissue distribution of the B7-2 costimulator in mice: abundant expression on dendritic cells in situ and during maturation in vitro. J Exp Med (1994) 3.66
Granulocytes, macrophages, and dendritic cells arise from a common major histocompatibility complex class II-negative progenitor in mouse bone marrow. Proc Natl Acad Sci U S A (1993) 3.25
Dendritic cells freshly isolated from human blood express CD4 and mature into typical immunostimulatory dendritic cells after culture in monocyte-conditioned medium. J Exp Med (1993) 3.09
Cancer antigens: immune recognition of self and altered self. J Exp Med (1994) 2.97
Direct activation of CD8+ cytotoxic T lymphocytes by dendritic cells. J Exp Med (1987) 2.94
Therapy of murine tumors with tumor peptide-pulsed dendritic cells: dependence on T cells, B7 costimulation, and T helper cell 1-associated cytokines. J Exp Med (1996) 2.92
Peptide-pulsed dendritic cells induce antigen-specific CTL-mediated protective tumor immunity. J Exp Med (1996) 2.69
Influenza virus-infected dendritic cells stimulate strong proliferative and cytolytic responses from human CD8+ T cells. J Clin Invest (1994) 2.57
Antigen acquisition by dendritic cells: intestinal dendritic cells acquire antigen administered orally and can prime naive T cells in vivo. J Exp Med (1993) 2.55
The B7/BB1 antigen provides one of several costimulatory signals for the activation of CD4+ T lymphocytes by human blood dendritic cells in vitro. J Clin Invest (1992) 2.51
Propagation of dendritic cell progenitors from normal mouse liver using granulocyte/macrophage colony-stimulating factor and their maturational development in the presence of type-1 collagen. J Exp Med (1994) 2.48
Interleukin 2 gene transfer into tumor cells abrogates tumorigenicity and induces protective immunity. J Exp Med (1990) 2.41
Murine dendritic cells loaded in vitro with soluble protein prime cytotoxic T lymphocytes against tumor antigen in vivo. J Exp Med (1996) 2.32
Dendritic cells stimulate primary human cytolytic lymphocyte responses in the absence of CD4+ helper T cells. J Exp Med (1990) 2.19
Bone marrow-generated dendritic cells pulsed with a class I-restricted peptide are potent inducers of cytotoxic T lymphocytes. J Exp Med (1995) 1.78
Constitutive expression of B7 restores immunogenicity of tumor cells expressing truncated major histocompatibility complex class II molecules. Proc Natl Acad Sci U S A (1993) 1.72
Granulocyte-macrophage colony-stimulating factor promotes differentiation and survival of human peripheral blood dendritic cells in vitro. J Clin Invest (1990) 1.72
Small amounts of superantigen, when presented on dendritic cells, are sufficient to initiate T cell responses. J Exp Med (1993) 1.66
TNF in combination with GM-CSF enhances the differentiation of neonatal cord blood stem cells into dendritic cells and macrophages. J Leukoc Biol (1992) 1.60
Murine dendritic cells pulsed in vitro with tumor antigen induce tumor resistance in vivo. Eur J Immunol (1994) 1.58
Precursor frequency analysis of human cytolytic T lymphocytes directed against autologous melanoma cells. Int J Cancer (1992) 1.57
T cell costimulation by B7/BB1 induces CD8 T cell-dependent tumor rejection: an important role of B7/BB1 in the induction, recruitment, and effector function of antitumor T cells. J Exp Med (1994) 1.43
Tumor antigen presentation by murine epidermal cells. J Immunol (1991) 1.39
Induction of CD8+ cytotoxic T lymphocytes by immunization with syngeneic irradiated HIV-1 envelope derived peptide-pulsed dendritic cells. Int Immunol (1993) 1.34
Expression and function of B7 on human epidermal Langerhans cells. J Immunol (1993) 1.33
Stimulation with dendritic cells decreases or obviates the CD4+ helper cell requirement in cytotoxic T lymphocyte responses. Eur J Immunol (1988) 1.22
Identification of T-cell epitopes: rapid isolation of class I-presented peptides from viable cells by mild acid elution. J Immunother Emphasis Tumor Immunol (1993) 1.20
Murine epidermal Langerhans cells and splenic dendritic cells present tumor-associated antigens to primed T cells. Eur J Immunol (1994) 1.16
Paracrine cytokine adjuvants in cancer immunotherapy. Annu Rev Immunol (1995) 1.15
Toward a genetic analysis of tumor rejection antigens. Adv Cancer Res (1992) 1.03
Dendritic cells induce peripheral T cell unresponsiveness under steady state conditions in vivo. J Exp Med (2001) 9.70
The induction of tolerance by dendritic cells that have captured apoptotic cells. J Exp Med (2000) 5.74
Presentation of exogenous protein antigens by dendritic cells to T cell clones. Intact protein is presented best by immature, epidermal Langerhans cells. J Exp Med (1989) 5.65
Dendritic cells exposed to human immunodeficiency virus type-1 transmit a vigorous cytopathic infection to CD4+ T cells. Science (1992) 5.61
Resting and sensitized T lymphocytes exhibit distinct stimulatory (antigen-presenting cell) requirements for growth and lymphokine release. J Exp Med (1984) 5.54
Differentiation of phagocytic monocytes into lymph node dendritic cells in vivo. Immunity (1999) 5.23
Developmental regulation of MHC class II transport in mouse dendritic cells. Nature (1997) 5.17
The cell surface of mouse dendritic cells: FACS analyses of dendritic cells from different tissues including thymus. Cell Immunol (1989) 4.96
Dendritic cells in the T-cell areas of lymphoid organs. Immunol Rev (1997) 4.41
Immunologic properties of purified epidermal Langerhans cells. Distinct requirements for stimulation of unprimed and sensitized T lymphocytes. J Exp Med (1986) 3.74
Dendritic cells are critical accessory cells for thymus-dependent antibody responses in mouse and in man. Proc Natl Acad Sci U S A (1983) 3.25
Clustering of dendritic cells, helper T lymphocytes, and histocompatible B cells during primary antibody responses in vitro. J Exp Med (1984) 3.23
Interleukin 1 enhances T-dependent immune responses by amplifying the function of dendritic cells. J Exp Med (1987) 2.97
Direct activation of CD8+ cytotoxic T lymphocytes by dendritic cells. J Exp Med (1987) 2.94
Transport of peptide-MHC class II complexes in developing dendritic cells. Science (2000) 2.62
Protein-specific helper T-lymphocyte formation initiated by dendritic cells. Science (1985) 2.55
Dendritic cells are the principal cells in mouse spleen bearing immunogenic fragments of foreign proteins. J Exp Med (1990) 2.54
Accessory cell-T lymphocyte interactions. Antigen-dependent and -independent clustering. J Exp Med (1986) 2.47
Dendritic cells induce T lymphocytes to release B cell-stimulating factors by an interleukin 2-dependent mechanism. J Exp Med (1983) 2.42
Antigen processing by epidermal Langerhans cells correlates with the level of biosynthesis of major histocompatibility complex class II molecules and expression of invariant chain. J Exp Med (1990) 2.39
Stimulation of lymphokine release from T lymphoblasts. Requirement for mRNA synthesis and inhibition by cyclosporin A. J Exp Med (1984) 2.24
Identification of macrophages and dendritic cells in the osteopetrotic (op/op) mouse. J Cell Sci (1993) 2.15
Macrophage factors which enhance the mixed leukocyte reaction initiated by dendritic cells. J Immunol (1989) 2.08
Use of the fluorescence activated cell sorter to enrich dendritic cells from mouse spleen. J Immunol Methods (1990) 2.04
Differential regulation of human blood dendritic cell subsets by IFNs. J Immunol (2001) 2.02
Tissue distribution of the DEC-205 protein that is detected by the monoclonal antibody NLDC-145. II. Expression in situ in lymphoid and nonlymphoid tissues. Cell Immunol (1995) 1.99
Properties of memory T lymphocytes isolated from the mixed leukocyte reaction. Proc Natl Acad Sci U S A (1985) 1.92
Systematic review and meta-analysis of the diagnostic and therapeutic role of water-soluble contrast agent in adhesive small bowel obstruction. Br J Surg (2010) 1.86
Fractalkine and macrophage-derived chemokine: T cell-attracting chemokines expressed in T cell area dendritic cells. Eur J Immunol (1999) 1.82
Distinct mechanisms of neonatal tolerance induced by dendritic cells and thymic B cells. J Exp Med (1991) 1.82
Monoclonal antibodies to LFA-1 and to CD4 inhibit the mixed leukocyte reaction after the antigen-dependent clustering of dendritic cells and T lymphocytes. J Exp Med (1987) 1.76
Five mouse homologues of the human dendritic cell C-type lectin, DC-SIGN. Int Immunol (2001) 1.74
Skin antigens in the steady state are trafficked to regional lymph nodes by transforming growth factor-beta1-dependent cells. Int Immunol (2001) 1.68
Antigen capture, processing, and presentation by dendritic cells: recent cell biological studies. Hum Immunol (1999) 1.57
A CD1a+/CD11c+ subset of human blood dendritic cells is a direct precursor of Langerhans cells. J Immunol (1999) 1.57
Contrasting effect of alpha/beta- and gamma-interferons on expression of macrophage Ia antigens. J Exp Med (1986) 1.55
Antigen presentation by dendritic cells after immunization with DNA encoding a major histocompatibility complex class II-restricted viral epitope. J Exp Med (1997) 1.53
The Chlamydomonas reinhardtii ODA3 gene encodes a protein of the outer dynein arm docking complex. J Cell Biol (1997) 1.53
Unusual phenotype of B cells in the thymus of normal mice. J Exp Med (1988) 1.51
New method for obliterative treatment of an anterior wall aneurysm in the internal carotid artery: encircling silicone sheet clip procedure--technical case report. Neurosurgery (2001) 1.47
Myeloid dendritic cells. J Leukoc Biol (1999) 1.40
Stimulation of the primary mixed leukocyte reaction. Crit Rev Immunol (1985) 1.40
Differentiation of an interleukin 3-dependent precursor B-cell clone into immunoglobulin-producing cells in vitro. Proc Natl Acad Sci U S A (1988) 1.36
Evaluation of rotation thrombelastography for the diagnosis of hyperfibrinolysis in trauma patients. Br J Anaesth (2008) 1.31
Lymphokine production by murine T cells in the mixed leukocyte reaction. J Exp Med (1988) 1.31
Macrophages, but not dendritic cells, accumulate colloidal carbon following administration in situ. J Cell Sci (1993) 1.27
A small number of anti-CD3 molecules on dendritic cells stimulate DNA synthesis in mouse T lymphocytes. J Exp Med (1989) 1.27
Characteristics of aneurysms arising from the horizontal portion of the anterior cerebral artery. Surg Neurol (2001) 1.24
Contrasting effects of TGF-beta 1 and TNF-alpha on the development of dendritic cells from progenitors in mouse bone marrow. Stem Cells (1997) 1.21
Immunogenicity: role of dendritic cells. Bioessays (1989) 1.20
Cloning and sequencing of the gene for Na+/H+ antiporter of Vibrio parahaemolyticus. Biochem Biophys Res Commun (1996) 1.20
The effect of immunosuppressive agents on the induction of nuclear factors that bind to sites on the interleukin 2 promoter. J Exp Med (1990) 1.18
Coexpression of NF-kappa B/Rel and Sp1 transcription factors in human immunodeficiency virus 1-induced, dendritic cell-T-cell syncytia. Proc Natl Acad Sci U S A (1995) 1.15
Cloning and sequencing of a novel Na+/H+ antiporter gene from Pseudomonas aeruginosa. Biochim Biophys Acta (1998) 1.15
Donor-derived chimerism in recipients of organ transplants. Hepatology (1993) 1.15
Low responsiveness of hepatitis B virus-transgenic mice in antibody response to T-cell-dependent antigen: defect in antigen-presenting activity of dendritic cells. Immunology (1993) 1.13
Dendritic cells: antigen presentation, accessory function and clinical relevance. Adv Exp Med Biol (1993) 1.09
Effect of L-arginine on the retention of macrophage tumoricidal activity. J Immunol (1991) 1.09
Is outer arm dynein intermediate chain 1 multifunctional? Mol Biol Cell (1996) 1.08
Transport of phagosomes in mouse peritoneal macrophages. J Cell Sci (1989) 1.08
Upregulation of MHC class II antigen on dendritic cells from hepatitis B virus transgenic mice by interferon-gamma: abrogation of immune response defect to a T-cell-dependent antigen. Immunology (1996) 1.07
Dendritic cell development and maturation. Adv Exp Med Biol (1997) 1.07
Cellular synergy in the manifestation of accessory cell activity for in vitro antibody response. J Immunol (1981) 1.04
Ursodeoxycholic acid protects hepatocytes against oxidative injury via induction of antioxidants. Biochem Biophys Res Commun (1999) 1.04
Effects of the deregulated expression of human interleukin-2 in transgenic mice. Int Immunol (1989) 1.04
Effects of intrathymic injection of organ-specific autoantigens, parietal cells, at the neonatal stage on autoreactive effector and suppressor T cell precursors. Eur J Immunol (1993) 1.03
Properties and sequence of the NhaA Na+/H+ antiporter of Vibrio parahaemolyticus. J Biochem (1994) 1.03
The changing epidemiology of spinal trauma: a 13-year review from a Level I trauma centre. Injury (2012) 1.03
An improved isolation method for murine migratory cutaneous dendritic cells. J Immunol Methods (1996) 1.00
Presence of B cell progenitors in the thymus. J Immunol (1997) 0.99
Pluripotent hemopoietic stem cells are c-kit<low. Proc Natl Acad Sci U S A (1997) 0.98
T cell studies in a peptide-induced model of systemic lupus erythematosus. J Immunol (2001) 0.97
Participation of Ia antigen-bearing nonmacrophage cells in the manifestation of accessory cell activity for in vitro antibody response. Microbiol Immunol (1980) 0.96
Membrane hyperpolarization by sperm-activating and -attracting factor increases cAMP level and activates sperm motility in the ascidian Ciona intestinalis. Dev Biol (1999) 0.96
Wheat germ agglutinin-positive cells in a stem cell-enriched fraction of mouse bone marrow have potent natural suppressor activity. Proc Natl Acad Sci U S A (1988) 0.95
Neuraminidase-treated macrophages stimulate allogenic CD8+ T cells in the presence of exogenous interleukin 2. J Exp Med (1988) 0.94
Properties of the Na+/H+ antiporter in Vibrio parahaemolyticus. J Biochem (1994) 0.94
Effect of human recombinant interleukin-6 on the proliferation of mouse hepatocytes in the primary culture. Immunobiology (1990) 0.93
Expansion of natural killer cells but not T cells in human interleukin 2/interleukin 2 receptor (Tac) transgenic mice. J Exp Med (1989) 0.92
Regulatory function of T lymphocytes in the immune response to polyvinyl pyrrolidone. I. Two categories of suppressor T cells. Cell Immunol (1978) 0.92
Sperm chemotaxis during the process of fertilization in the ascidians Ciona savignyi and Ciona intestinalis. Dev Biol (1993) 0.92
Effect of delaying same-admission cholecystectomy on outcomes in patients with diabetes. Br J Surg (2013) 0.92
Relevance of lymph node metastasis along the superior mesenteric vein in gastric cancer. Br J Surg (2011) 0.91
Ontogeny of thymic B cells in normal mice. Cell Immunol (1991) 0.91
A new videopupillography. Ophthalmologica (1970) 0.90
An interleukin-4-dependent precursor clone is an intermediate of the differentiation pathway from an interleukin-3-dependent precursor clone into myeloid cells as well as B lymphocytes. Int Immunol (1989) 0.90
The antiemetic profile of Y-25130, a new selective 5-HT3 receptor antagonist. Eur J Pharmacol (1991) 0.89
Cyclic AMP- and calmodulin-dependent phosphorylation of 21 and 26 kda proteins in axoneme is a prerequisite for SAAF-induced motile activation in ascidian spermatozoa. Dev Growth Differ (2000) 0.87
The NhaB Na+/H+ antiporter is essential for intracellular pH regulation under alkaline conditions in Escherichia coli. J Biochem (1994) 0.87
Hypervascular liver metastasis from hypovascular ductal cell carcinoma of the pancreas. Intern Med (2001) 0.86
Cell-mediated and humoral immune responses in mice. II. Sensitizing conditions for delayed-type hypersensitivity. Int Arch Allergy Appl Immunol (1977) 0.86
Functional analyses of thymic CD5+ B cells. Responsiveness to major histocompatibility complex class II-restricted T blasts but not to lipopolysaccharide or anti-IgM plus interleukin 4. J Exp Med (1990) 0.86
Selective non-operative management of penetrating abdominal injury in Great Britain and Ireland: survey of practice. Injury (2011) 0.85
Proton magnetic resonance assay of total and taurine-conjugated bile acids in bile. J Lipid Res (1999) 0.85
Ontogeny of 'macrophage' function. III. Manifestation of high accessory cell activity for primary antibody response by Ia+ functional cells in newborn mouse spleen in collaboration with Ia- macrophages. Immunology (1982) 0.85
Activation of thymic B cells by signals of CD40 molecules plus interleukin-10. Eur J Immunol (1995) 0.85
Separation of hematopoietic stem cells into two populations and their characterization. Blood (1992) 0.85
Macrophage-activating factor extracted from mycoplasmas. Cancer Immunol Immunother (1991) 0.85